Swiss Pharmaceuticals IGF-1 EXTREME 60caps

Popis

Swiss Pharmaceuticals IGF-1 EXTREME – Product Overview

Název produktu: IGF-1 EXTREME
Manufacturer: Swiss Pharmaceuticals
Obal: 60 capsules per bottle
Dávkování: The recommended dosage and usage instructions are typically provided on the product label, but a common regimen may suggest 1-2 capsules taken daily, preferably around workout times for enhanced benefits. It’s crucial to follow specific dosing recommendations and consult with a healthcare provider before use.

Contents and Ingredients:
The primary ingredient in IGF-1 EXTREME is Insulin-like Growth Factor 1 (IGF-1). This is a peptide hormone similar in molecular structure to insulin. Additional ingredients often include excipients, binders, and capsules (which could be gelatin based), but you should verify the ingredient list on the packaging for precise formulation.

Description and Functionality:

IGF-1 EXTREME is positioned as a powerful anabolic supplement designed to support muscle growth and recovery through the natural hormone IGF-1. This hormone is predominant in promoting cell growth and regeneration, enhancing both muscle tissue development and the general repair processes within the body.

Mechanismus působení:
IGF-1 functions synergistically with growth hormone (GH). When released from the liver after being stimulated by GH, IGF-1 plays a vital role in cellular processes, thereby assisting in muscle hypertrophy and recovery post-exercise.

Výhody: The key benefits associated with Swiss Pharmaceuticals IGF-1 EXTREME include:

• Lean Muscle Growth: Aids in increasing muscle size without the concomitant gain of fat.
• Improved Recovery: Speeds up the healing process of muscles and tissues post-workout.
• Muscle Definition: Contributes to enhanced muscle tone and definition.
• Vylepšení síly: Increases overall muscle power for better performance during workouts.
• Protein Synthesis Boost: Encourages increased production of proteins critical for muscle repair and growth.
• Fat Reduction: May lead to a decrease in body fat percentage.
• Endurance Improvement: Increases stamina during physical activities.
• Libido Stimulation: Potentially boosts sexual function and virility.
• Nerve and Cell Healing: Accelerates recovery in damaged nerves and other cells.
• Anti-Aging Effects: Potentially slows down age-related decline in muscle function and recovery.

Final Note:
It is important to highlight that while Swiss Pharmaceuticals IGF-1 EXTREME provides a convenient oral supplement form of IGF-1, prospective users should consult healthcare professionals to ensure its safety, particularly for those with pre-existing conditions or those taking other medications. Additionally, the benefits and results may vary based on individual responses and should be coupled with proper diet and exercise for optimum effectiveness.

Ecco una lista di referenze scientifiche per gli ingredienti menzionati nella descrizione di Swiss Pharmaceuticals IGF-1 EXTREME:

1. Bouchard C., & Rankinen T. (2001). Individual differences in response to regular exercise. Medicine and Science in Sports and Exercise, 33(6), S446-S451. PubMed

2. D’Ercole A. J., & Yeager M. (2008). Insulin-like growth factors and their binding proteins: a new age for clinically useful, commercially important hormones. Výzkum růstového hormonu a IGF, 18(6), 465-478. PubMed

3. Frojd C., et al. (1995). The role of insulin-like growth factor in hormonal regulation of muscle and bone metabolism. Journal of Clinical Endocrinology & Metabolism, 80(8), 2309-2312. PubMed

4. Möller N., & Jørgensen J. O. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism: a review. Výzkum růstového hormonu a IGF, 19(2), 121-127. PubMed

5. Veldhuis J. D., & Iranmanesh A. (1996). Neuroendocrine regulation of growth hormone secretion: Insights from the human model. Journal of Clinical Endocrinology & Metabolism, 81(3), 967-979. PubMed

6. Sweeney T. E., et al. (2014). Role of insulin-like growth factors in non-small cell lung cancer: biological and clinical implications. Clinical Cancer Research, 20(1), 330-340. PubMed

7. Gaukrodger N., et al. (1996). Aging-related changes in serum insulin-like growth factor levels. Klinická endokrinologie,